INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
CE
Chapman Rowan EDirector
NTRANatera, Inc.
Grant or award
A—
103 sh
Jun 26, 2026Jun 30, 2026
Page 583 of 1701
← PrevNext →
traded Jun 26, 2026
+4d
SEC Form 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
706 sh
Jun 4, 2026Jun 30, 2026
traded Jun 4, 2026
+26dSEC Form 4

Evidence

5
DB
Dorrance Bennett JRDirector
CPBCAMPBELL'S Co
Grant or award
A—
1,855 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
60 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
SC
Shackley Brian CharlesSVP, Chief Accounting Officer
AVAVAeroVironment Inc
Option exercise
M—
953 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$22K
230 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
15.7K sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC Form 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$327K
39.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$390
4 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
13.6K sh
Jun 11, 2026Jun 30, 2026
traded Jun 11, 2026
+19dSEC Form 4

Evidence

5
MF
Mehmel Robert FPresident and COO
GFFGRIFFON CORP
Open-market sale · 10b5-1 plan
SELL$4,999
52 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

5
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$419K
51.6K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

5
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M$5,789
706 sh
Jun 4, 2026Jun 30, 2026
traded Jun 4, 2026
+26dSEC Form 4

Evidence

4
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$386K
16.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$188K
12.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

4
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
16.8K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

4
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
111.8K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

3
SW
Silberman Michael WChief Legal Officer
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
30.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

3
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

3
PS
Puri SumeetChief Accounting Officer
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
17.6K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

3
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Option exercise · 10b5-1 plan
M—
3,287 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

2
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Option exercise · 10b5-1 plan
M$71K
3,287 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$211K
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$100K
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

2
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M$598K
143.0K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

2
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M$467K
111.8K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
2,500 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

1
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Open-market sale · 10b5-1 plan
SELL$1,528
39 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
63.2K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

0
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$22K
1,837 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

0
KN
Kroeker NathanCCO and Interim CFO
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
70.6K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$134K
11.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Option exercise · 10b5-1 plan
M$25K
4,896 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
88.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
1,001 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
1,336 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
8,897 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

0
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Option exercise · 10b5-1 plan
M—
39.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence